resources
Investigation of subcutaneous monoclonal antibody formulations
Applications Note
Preview - This content has been restricted to logged in users only.
There is a strong patient preference for subcutaneous (SC) delivery of parenteral drugs. SC therapies are safer to administer and less time-consuming.
Applications Note
There is a strong patient preference for subcutaneous (SC) delivery of parenteral drugs. SC therapies are safer to administer and less time-consuming than intravenous (IV) therapies and they do not require supervision by medical professionals, making them suitable for self-managed home care treatments.